Related Experiment Video
Updated: Sep 11, 2025

12:35
Comparison of Three Different Methods for Determining Cell Proliferation in Breast Cancer Cell Lines
Published on: September 3, 2016
19.6K
Breast Cancer Cell Line-Specific Responses to Insulin: Effects on Proliferation and Migration
Mattia Melloni1, Domenico Sergi1, Angelina Passaro1
1Department of Translational Medicine, University of Ferrara, Via Luigi Borsari 46, 44121 Ferrara, Italy.
International Journal of Molecular Sciences
|August 14, 2025
Summary
High insulin levels, not high glucose, impact breast cancer (BC) progression. Hyperinsulinemia promotes proliferation in hormone-responsive BC cells and migration in triple-negative cells, suggesting targeted insulin pathway therapies.
Area of Science:
- Endocrinology
- Oncology
- Cell Biology
Background:
- The diabetic microenvironment, marked by hyperglycemia and hyperinsulinemia, influences breast cancer (BC) progression.
- Cellular mechanisms linking the diabetic microenvironment to BC progression require further elucidation.
Purpose of the Study:
- To investigate the effects of supra-physiological glucose and insulin levels on hormone-responsive (MCF-7) and triple-negative (MDA-MB-231) BC cell models.
- To analyze the impact of hyperinsulinemia on PI3K/AKT and MAPK pathways, cell proliferation, cell cycle, and migration in distinct BC subtypes.
Main Methods:
- Exposure of MCF-7 and MDA-MB-231 cells to high glucose and/or high insulin conditions.
- Analysis of AKT and MAPK pathway activation (phosphorylation).
- Assessment of cell proliferation, cell cycle distribution, and cell migration.
Main Results:
- High insulin activated the AKT pathway in both cell lines.
- Hyperinsulinemia stimulated proliferation and altered cell cycle distribution only in MCF-7 cells.
- High glucose alone did not affect proliferation; high insulin did not further increase proliferation when combined with high glucose.
- MDA-MB-231 cells showed increased migration but not proliferation after chronic hyperinsulinemia exposure.
- AKT inhibition blocked the proliferative stimulus in MCF-7 cells.
Conclusions:
- Chronic hyperinsulinemia, not hyperglycemia, exerts subtype-specific effects on breast cancer.
- Hyperinsulinemia promotes proliferation in hormone-responsive BC cells via AKT activation.
- Hyperinsulinemia enhances migration in triple-negative BC cells.
- Targeting insulin pathways may offer therapeutic potential for specific breast cancer subtypes.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
1.5K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.5K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K

